The FDA should decline to enforce a mifepristone ban, argue Dean Rebouche and co-authors David S. Cohen and Greer Donley in this Guardian op-ed. Read More

Dean Rebouche joins Background Briefing to discuss why she thinks the FDA should decline to enforce any ban on mifepristone. Read More

Dean Rachel Rebouche says an appellate court ruling on access to abortion pills has added confusion, putting the issue in “uncharted territory.” Read More

Dean Rebouche joined the National Constitution Center’s We the People podcast to discuss the legality of abortion pills. Read More

Dean Rebouche weighs the Supreme Court’s options on access to mifepristone while the appeals process plays out. Read More

A patent licensing dispute between Salesforce and WSOU has prompted broader discovery than is typical in the West Texas court hearing the matter, says Prof. Paul Gugliuzza. Read More

Dean Rebouche explains the legal whirlwind that has brought abortion back to the Supreme Court and sorts out what could happen next in this Q&A with Yahoo News. Read More

In “Bankruptcy Amnesia,” Prof. Jonathan Lipson pushes back against a narrative he says deflects from the Sackler family’s role in the opioid crisis. Read More

Prof. Paul Gugliuzza shares his insights into a conflict between two strong personalities on the Federal Circuit bench. Read More

Judge Robert Drain, who presided over the Purdue Pharma litigation, has joined the firm representing Purdue. Prof. Jonathan Lipson says that despite the judge’s good intentions, the optics are troubling. Read More